JESSICA BASS: Open Payments
NPI 1558080739 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$187 in 9 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $139 · 2025 $187
Food & beverage: $187
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $58 |
| Janssen Pharmaceuticals, Inc | 2 | $45 |
| Lundbeck LLC | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $23 |
Products named: VRAYLAR, SPRAVATO, CAPLYTA, Auvelity, REXULTI, ABILIFY ASIMTUFII.
Industry payments across MS — which companies pay providers there.
